These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23011176)
1. Acetazolamide for the management of chronic metabolic alkalosis in neonates and infants. Tam B; Chhay A; Yen L; Tesoriero L; Ramanathan R; Seri I; Friedlich PS Am J Ther; 2014; 21(6):477-81. PubMed ID: 23011176 [TBL] [Abstract][Full Text] [Related]
2. Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease. Moffett BS; Moffett TI; Dickerson HA Am J Ther; 2007; 14(4):331-5. PubMed ID: 17667206 [TBL] [Abstract][Full Text] [Related]
3. Acetazolamide Therapy for Metabolic Alkalosis in Pediatric Intensive Care Patients. López C; Alcaraz AJ; Toledo B; Cortejoso L; Gil-Ruiz MA Pediatr Crit Care Med; 2016 Dec; 17(12):e551-e558. PubMed ID: 27748700 [TBL] [Abstract][Full Text] [Related]
4. Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients. Moviat M; Pickkers P; van der Voort PH; van der Hoeven JG Crit Care; 2006 Feb; 10(1):R14. PubMed ID: 16420662 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Arginine Hydrochloride and Acetazolamide for the Correction of Metabolic Alkalosis in Pediatric Patients. Heble DE; Oschman A; Sandritter TL Am J Ther; 2016; 23(6):e1469-e1473. PubMed ID: 25379736 [TBL] [Abstract][Full Text] [Related]
6. Acetazolamide therapy for metabolic alkalosis in critically ill pediatric patients. Bar A; Cies J; Stapleton K; Tauber D; Chopra A; Shore PM Pediatr Crit Care Med; 2015 Feb; 16(2):e34-40. PubMed ID: 25647140 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy of acetazolamide treatment of patients with hypercapnia and superimposed metabolic alkalosis]. Prieto de Paula JM; Villamandos Nicás V; Cancelo Suárez P; del Portillo Rubí A; Guillem Ares E; Prada Mínguez A; Sanz de la Fuente H Rev Clin Esp; 1997 Apr; 197(4):237-40. PubMed ID: 9254398 [TBL] [Abstract][Full Text] [Related]
8. Acetazolamide in critically ill neonates and children with metabolic alkalosis. Andrews MG; Johnson PN; Lammers EM; Harrison DL; Miller JL Ann Pharmacother; 2013 Sep; 47(9):1130-5. PubMed ID: 24259727 [TBL] [Abstract][Full Text] [Related]
9. Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial. Mazur JE; Devlin JW; Peters MJ; Jankowski MA; Iannuzzi MC; Zarowitz BJ Crit Care Med; 1999 Jul; 27(7):1257-61. PubMed ID: 10446816 [TBL] [Abstract][Full Text] [Related]
10. Acetazolamide in the treatment of metabolic alkalosis in critically ill patients. Marik PE; Kussman BD; Lipman J; Kraus P Heart Lung; 1991 Sep; 20(5 Pt 1):455-9. PubMed ID: 1894525 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation. Faisy C; Mokline A; Sanchez O; Tadié JM; Fagon JY Intensive Care Med; 2010 May; 36(5):859-63. PubMed ID: 20217045 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients. Heming N; Faisy C; Urien S Crit Care; 2011; 15(5):R213. PubMed ID: 21917139 [TBL] [Abstract][Full Text] [Related]
14. Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit? Heming N; Urien S; Faisy C Crit Care; 2012 Aug; 16(4):318. PubMed ID: 22866939 [TBL] [Abstract][Full Text] [Related]
15. Intravenous or Oral Acetazolamide for Treatment of Diuretic-Induced Alkalosis in Patients With Heart Failure. Addison JD; Peterson EJ; Meyenburg L Ann Pharmacother; 2023 Nov; 57(11):1241-1247. PubMed ID: 36803069 [TBL] [Abstract][Full Text] [Related]
16. Abolition of pentagastrin-stimulated alkaline tide using the carbonic anhydrase inhibitor acetazolamide. Regev A; Drori R; Fraser GM; Niv Y Isr Med Assoc J; 2001 Apr; 3(4):247-50. PubMed ID: 11344834 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Alkalosis in the Pediatric Patient: Treatment Options in the Pediatric ICU or Pediatric Cardiothoracic ICU Setting. Tobias JD World J Pediatr Congenit Heart Surg; 2020 Nov; 11(6):776-782. PubMed ID: 33164684 [TBL] [Abstract][Full Text] [Related]
18. Effect of metabolic alkalosis on respiratory function in patients with chronic obstructive lung disease. Bear R; Goldstein M; Phillipson E; Ho M; Hammeke M; Feldman R; Handelsman S; Halperin M Can Med Assoc J; 1977 Oct; 117(8):900-3. PubMed ID: 21028 [TBL] [Abstract][Full Text] [Related]
19. Effect of acetazolamide on post-NIV metabolic alkalosis in acute exacerbated COPD patients. Fontana V; Santinelli S; Internullo M; Marinelli P; Sardo L; Alessandrini G; Borgognoni L; Ferrazza AM; Bonini M; Palange P Eur Rev Med Pharmacol Sci; 2016; 20(1):37-43. PubMed ID: 26813451 [TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors in patients with respiratory failure and metabolic alkalosis: a systematic review and meta-analysis of randomized controlled trials. Tanios BY; Omran MO; Noujeim C; Lotfi T; Mallat SS; Bou-Khalil PK; Akl EA; Itani HS Crit Care; 2018 Oct; 22(1):275. PubMed ID: 30371345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]